Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Invest Dermatol. 2019 Apr 19;139(5):984–990.e1. doi: 10.1016/j.jid.2019.02.014

Table 1.

Summary of the representative preclinical mouse models of human atopic dermatitis

Category advantages /limitations Examples Characteristics References
Inbred models
Pros: resembles natural course of human AD; enhanced percutaneous sensitization to haptens and allergens Flaky tail (ma/ma, Flgft/ft)
  • Recapitulates barrier defect in a subset of human AD

  • Combined genetic alteration of Flg and Tmem79

(Fallon et al., 2009, Sasaki et al., 2013, Saunders et al., 2013)
Cons: lack of genetic information in some strains; variable induction protocols when combined with hapten- or allergen-challenges; some models do not spontaneously develop dermatitis under SPF conditions NC/Nga
  • Spontaneous onset in conventional housing condition

  • Genetic determinant linked to immune-related genes

(Kohara et al., 2001, Matsuda et al., 1997)
Genetically-engineered models
Pros: useful in elucidating gene-specific functions in vivo; powerful when crossed with other strains Overexpression
IL-4 (K14-IL4 Tg)
IL-13 (K5-tTA-IL13 Tg)
  • Keratinocyte-specific overexpression of type 2 cytokines recapitulating human AD including chronic parenchymal changes

(Chan et al., 2006, Zheng et al., 2009)
Cons: time-consuming and expensive to generate; undesirable effect by unexpected gene expression or alteration (i.e. variable penetrance, inefficiency of Cre) IL-31 (EF1α-IL31 or Eμ-Lck-IL31 Tg)
  • Pruritus and disruption of the skin barrier

(Dillon et al., 2004)
TSLP (K5-rtTA-TSLP Tg)
IL-18 (K14-IL18 Tg)
IL-33 (K14-IL33 Tg)
  • Keratinocyte expression of type 2 cytokines that activate innate lymphoid cells

(Imai et al., 2013, Konishi et al., 2002, Yoo et al., 2005)
JAK1 (Jak1spade/spade)
  • JAK1 hyperactivation leading to barrier dysfunction

(Yasuda et al., 2016)
Ablation
ADAM17 (Adam17fl/fl Sox9Cre)
  • Spontaneous dysbiosis and eczematous skin inflammation

(Kobayashi et al., 2015)
CARMA-1 (unmodulated)
  • N-ethyl-N-nitrosourea-induced, genome-wide mutagenesis model

  • Mutation in mouse ortholog of CARMA-1/CARD11

(Jun et al., 2003)
Induced models by exogenous agents
Pros: time-controlled induction; applicable to various mouse strains
Cons: non-standardized products for some allergens; variable protocols (doses and durations); labor-intensive (daily applications)
Hapten- induced (ex. oxazolone, TNCB)
Allergen-induced (ex. ovalbumin, house dust mite)
  • AD-like inflammation induced by repeated challenge

  • Ambiguous distinction between AD and allergic contact dermatitis

(Kitagaki et al., 1995, Kitagaki et al., 1997, Matsuoka et al., 2003, Spergel et al., 1998, Wang et al., 2007)
MC903 (calcipotriol)- induced
  • High reproducibility of AD-like responses in various strains

(Kim et al., 2013, Li et al., 2006, Myles et al., 2016, Naidoo et al., 2018, Oetjen et al., 2017)